番茄社区

Yet advisors were not inclined to take back approval for bleeding reversal agent

Drug discontinuations may have leveled any benefit in CLEAR OASIS 9 trial

Craig Spencer, MD, talks about the symptoms and his treatment at Bellevue Hospital

With few exceptions, treatment can be shortened to 7 days, researcher says

Fewer cerebral ischemic events also observed with care teams quicker to give blood

Temperature management device did result in less fever in the INTREPID trial

Our fragile patients are increasingly dependent on a crumbling healthcare system

In-tandem reductions at VA centers suggest antimicrobial stewardship works, researchers say

To some extent, it's to be expected, researchers note

Clinicians must "uncomfortably" examine bias in life-and-death decisions, says expert

False positives, alarm fatigue complicate their use, experts say

Harms seen without any compensating survival benefit

Benefit limited to patients with severe illness or elevated minimum inhibitory concentrations

At-risk older adults should be screened, referred early for rehabilitation, researcher urges